Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
1 clinical trials · Condition
◉ Watch Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
| Record | Firm | Date |
|---|---|---|
| Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) (NCT06049212) | Merck Sharp & Dohme LLC | 2023-10-26 |
Track Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) automatically
Every clearance here is in the API, with alerts when new ones post.